Clinical Core
临床核心
基本信息
- 批准号:10456006
- 负责人:
- 金额:$ 42.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerometerAdherenceAdverse effectsAdvertisementsAgeAnxietyAudiotapeAurasAwarenessBackBehaviorBiostatistics CoreCenters of Research ExcellenceChronic DiseaseClinicalClinical Trials Data Monitoring CommitteesCollaborationsCollectionCompassionComplementary HealthDataData ReportingDevicesDoseEcological momentary assessmentEducationEffectivenessEmergency SituationEnrollmentEnsureExclusion CriteriaExperimental DesignsFemaleFrequenciesGenderGoalsGood Clinical PracticeHeadacheHealth AllianceHealth educationIndividualInstitutional Review BoardsIntegrative MedicineInterventionIntervention StudiesMeasurementMeasuresMediationMedicalMenstrual cycleMental DepressionMethodologyMigraineMindfulness TrainingMonitorOutcomePain interferencePatient Self-ReportPatientsPhysiciansPremenopauseProtocol ComplianceProtocols documentationPsychologistQuality of lifeRandomizedRecurrenceResearchSafetySelf EfficacySupervisionTrainingTraining and EducationTranscutaneous Electric Nerve Stimulationafferent nervearmbasebody-mindchronic painclinically relevantdata registrydesigndisabilityeffectiveness studyemotion dysregulationexperiencehuman subjectmindfulnessmindfulness meditationmindfulness-based stress reductionmulti-component interventionperceived stressrecruitrespiratorytraitvagus nerve stimulation
项目摘要
The Clinical Core (CC) of the Center of Excellence for Research on Complementary and Integrative
Health (CERCIH) will facilitate the clinical activities of the three proposed Projects, providing support
and expertise to unify all clinical aspects of our human subjects experimental designs. The CC will
recruit, screen, characterize, and enroll 120 subjects with recurrent migraine headaches and 30 age-
and gender-matched healthy controls. Mostly using physician referrals and our Research Patient Data
Registry (RPDR), the core will utilize a highly skilled and experienced team to supervise and implement
these goals. The CC will be the central randomization point for Projects 1, 2, and 3 and provide the
network and referrals to support recruitment of all subjects and ensure adherence to the common
inclusion/exclusion criteria utilized for all three Projects. The CC will randomize subjects using a 2 x 2
design: Mindfulness-Based Stress Reduction (MBSR) versus Health Education Training (HET) X
transcutaneous vagus nerve stimulation (tVNS) compared to sham tVNS. The CC will ensure that the
MBSR and HET are delivered correctly and adhere to protocol. The CC will recruit, train and supervise
the MBSR group leaders who will perform all of the necessary trainings and education sessions. The
CC will refine and implement the methodologies, including audiotaping and fidelity rating of training
sessions, to ensure group leader protocol compliance. The CC will use accelerometer-based, ecologic
momentary assessment to measure mindfulness practice dose during the study so as to ensure
accurate measurement of individual subjects’ level of mindfulness practice. The CC will oversee and
integrate our respiratory-gated tVNS approach with MBSR and HET sessions, including the sham
tVNS, where needed. The CC will ensure that devices will be available to accommodate all subjects
and that the units are reliably utilized within each session. In collaboration with the biostatistics core,
the CC will collect self-report measures to investigate relevant clinical correlates such as headache
frequency and intensity, days of lost function, perceived stress, and pain interference. The CC will also
collect self-report data for mediation and moderation analyses, including chronic disease self-efficacy,
perceived control, anxiety, depression, trait mindfulness, mindfulness practice behaviors, self-
compassion, interoceptive awareness, and emotional dysregulation. While infrequent, the CC will be
available to provide medical coverage and assessment for any medical or psychiatric adverse effect
from tVNS and/or mindfulness. The CC will meet once per year with the Data Safety Monitoring Board
to review and discuss any new internal or pertinent external data, as well as to monitor safety,
effectiveness, and study conduct. The CC will also coordinate any necessary independent monitoring
activities as required, and successfully manage one common IRB across the 3 projects.
临床核心(CC)的卓越中心的研究互补和综合
卫生部(CERCIH)将为三个拟议项目的临床活动提供便利,
和专业知识来统一我们人类受试者实验设计的所有临床方面。 CC将
招募、筛选、表征并登记120名复发性偏头痛患者和30名年龄
和性别匹配的健康对照。主要使用医生转诊和我们的研究患者数据
注册处(RPDR),核心将利用一个高度熟练和经验丰富的团队来监督和实施
CC将是项目1、2和3的中心随机化点,并提供
网络和转介,以支持所有受试者的招募,并确保遵守共同的
所有三个项目均采用入选/排除标准。CC将使用2x2
设计:正念--基于正念的减压(MBSR)与健康教育训练(HET)X
经皮迷走神经刺激(tVNS)与假tVNS相比。CC将确保
正念减压疗法和健康教育疗法正确实施并遵守方案。CC将招募、培训和监督
正念减压小组的领导人将执行所有必要的培训和教育课程。
消委会会改善及推行有关方法,包括录音及评核培训的可信度
会议,以确保组长协议的遵守。CC将使用基于加速计的,生态
在研究期间进行瞬时评估以测量正念练习剂量,以确保
精确测量个体受试者的正念练习水平。 CC将监督和
将我们的呼吸阻断tVNS方法与MBSR和HET疗程(包括假手术)相结合
tVNS(如需要)。CC将确保设备可用于容纳所有受试者
并且在每个会话内可靠地利用这些单元。 与生物统计学核心合作,
CC将收集自我报告测量,以调查相关临床相关因素,如头痛
频率和强度,失去功能的天数,感知压力和疼痛干扰。CC还将
收集自我效能报告资料作中介及适度分析,包括慢性病自我效能,
知觉控制,焦虑,忧郁,特质正念,正念练习行为,自我控制
同情心、内感受意识和情绪失调。 虽然不常见,但CC将
提供医疗保险和评估任何医疗或精神不良影响
从tVNS和/或正念。CC将每年与数据安全监测委员会举行一次会议
审查和讨论任何新的内部或相关外部数据,以及监测安全性,
有效性和研究行为。 协调委员会还将协调任何必要的独立监测
活动,并成功管理3个项目的一个共同IRB。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUCE R ROSEN其他文献
BRUCE R ROSEN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUCE R ROSEN', 18)}}的其他基金
Upgrade the 14T Ultrahigh Field Horizontal MR Scanner for Rodent and ex-vivo Imaging
升级 14T 超高场水平 MR 扫描仪,用于啮齿动物和离体成像
- 批准号:
10175835 - 财政年份:2021
- 资助金额:
$ 42.74万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 42.74万 - 项目类别:
Fellowship Programs














{{item.name}}会员




